NEW YORK (GenomeWeb News) – 454 Life Sciences has used software made by Celoxica Holdings to help it in its project to sequence the Neandertal genome, according to a British online news service.
Life Style Extra cited a Celoxica statement saying that 454 has “invested” $1.5 million in the company’s products, which it uses “to help accelerate the computing performance” of its sequencing technology.
According to LSE, the Celoxica RC2000 board provides the FPGA co-processing engine for the 454 sequencer, and that 454 uses Celoxica's DK Design Suite to program the algorithms in the FPGA.
Officials from 454 were not immediately available to confirm the report.
According to Celoxica's website, the company provides C-based design and behavioral synthesis tools. It provides electronic system level (ESL) co-design products that incorporate ANSI-C, Handel-C, and SystemC languages.